• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VivoSim Labs, Inc. - Common Stock (NQ:VIVS)

0.2608 -0.0307 (-10.53%)
Official Closing Price Updated: 4:15 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 149,183,693
Open 0.2799
Bid (Size) 0.2426 (500)
Ask (Size) 0.2445 (4,000)
Prev. Close 0.2915
Today's Range 0.2435 - 0.3808
52wk Range 0.1180 - 3.400
Shares Outstanding 8,716,953
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
VivoSim Labs, Inc. (NASDAQ: VIVS) Surges, Anthropic (NASDAQ: ANT) Opening Day and More Tech Inside
November 19, 2026
Via AB Newswire
Topics Artificial Intelligence Initial Public Offering
US Top Movers for Nov. 19, 2026: Gainers and Losers ↗
November 19, 2026
Via Chartmill

Performance

52-Week Range 92.3% below 52-week high
0.2608
0.1252W Low 3.4052W High
1 Week 31.5% below 1-week high
0.121W Low 0.381W High

VivoSim Labs, Inc. - Common Stock (VIVS) traded between $0.12 and $3.40 over the past 52 weeks and last traded at $0.26, 92.3% below its 52-week high. Over the past week it ranged between $0.12 and $0.38.

Past 12 Months
+110.8%
+47.3%
-8.8%
-80.8%
-86.1%
-88.0%
1W +$0.14
1M +$0.08
3M -$0.03
6M -$1.10
YTD -$1.62
1Y -$1.91

VIVS was -88.0% over the past year, -80.8% over six months, -86.1% year to date, +110.8% in the last week.

12 Months vs Market
VIVS
-88.0%
DIA
+5.0%
SPY
+5.7%
QQQ
+3.9%
IWM
+12.0%

Over the past 12 months VIVS returned -88.0% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 9.64× 3-mo avg
Today 149,183,693 3-mo avg 15.5M
1W
189.8M
1M
42.3M
3M
15.5M
6M
10.7M
YTD
6.5M
1Y
5.8M

VIVS most recently traded 149,183,693 shares against a 3-month average daily volume of 15.5M.

More News

Read More
Most Active Stocks on Nov. 19: VIVS, CHSN and NVDA Top Volume ↗
November 19, 2026
Via Chartmill
US Top Stock Movers: VIVS Gains 79.17%, PIIIW Falls 75.56% in Today's Session ↗
November 19, 2026
Via Chartmill
Gap Stocks on November 19, 2026: Vivid Seats and NewGenIvf Lead Movers ↗
November 19, 2026
Via Chartmill
Premarket Small-Cap Movers: Nov. 19, 2026 Gainers and Losers ↗
November 19, 2026
Via Chartmill
News headline image
VivoSim Labs Signs Seven-Figure Agreement with a Top-10 Global Pharmaceutical Company; Expects to Exceed Its 500%+ Revenue Growth Guidance for Fiscal 2027
November 19, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting
November 16, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Labs and Chemveda Move Human-Tissue Testing Earlier in AI Drug Development
November 13, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
A Billionaire Investor Links Cancer Treatment and Wireless Technology as AI Pharmaceutical Testing Gains Ground
November 11, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
VivoSim Labs to Showcase Multiparametric Human 3D Tissue Safety Data at the American College of Toxicology (ACT) 47th Annual Meeting
November 10, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
Post-Midterm Market Sectors and Companies Inside to Watch
November 05, 2026
Via AB Newswire
News headline image
3 Stocks Under $1: INO, VIVS, FNUC in Focus for November
November 03, 2026
Via AB Newswire
News headline image
VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test
November 03, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
Next-Gen Biotech: RXRX, OCGN, SNTI, VIVS, ONCO Stocks to Watch
October 28, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling
October 21, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
5 Biotech Stocks’ TCRT, IGC, PDSB, PFAI, Acquisition, Alzheimer’s, Cardio and Cancer Research Milestones
October 13, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch
October 07, 2026
Via AB Newswire
Topics Animal Testing Artificial Intelligence
News headline image
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
October 07, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
2026 Biotech Watchlist IBRX, PACB, IGC, VIVS Lead 7 Stocks in Focus
October 01, 2026
Via AB Newswire
News headline image
2026 Nanocap Stocks to Watch: IGC, KNRX, GYGY, ARAY Lead Watchlist Now See More Inside!
September 28, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs
September 28, 2026
Via AB Newswire
News headline image
Greenland Stocks in Focus: GLND, GRML, CRML Lead the Watchlist More Names Inside
September 21, 2026
Via AB Newswire
Topics Government
News headline image
VivoSim Labs Inc. (NASDAQ: VIVS) Takes Aim at Pharma’s 92% Drug-Failure Problem
September 21, 2026
Via AB Newswire
Topics Animal Testing
News headline image
High-Impact Stocks DRK, VIVS, AEMD, GMG in the News
September 17, 2026
Via AB Newswire
Topics Artificial Intelligence Energy

Frequently Asked Questions

Is VivoSim Labs, Inc. - Common Stock publicly traded?
Yes, VivoSim Labs, Inc. - Common Stock is publicly traded.
What exchange does VivoSim Labs, Inc. - Common Stock trade on?
VivoSim Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for VivoSim Labs, Inc. - Common Stock?
The ticker symbol for VivoSim Labs, Inc. - Common Stock is VIVS on the Nasdaq Stock Market
What is the current price of VivoSim Labs, Inc. - Common Stock?
The current price of VivoSim Labs, Inc. - Common Stock is 0.2608
When was VivoSim Labs, Inc. - Common Stock last traded?
The last trade of VivoSim Labs, Inc. - Common Stock was at 11/20/26 04:15 PM ET
What is the market capitalization of VivoSim Labs, Inc. - Common Stock?
The market capitalization of VivoSim Labs, Inc. - Common Stock is 2.27M
How many shares of VivoSim Labs, Inc. - Common Stock are outstanding?
VivoSim Labs, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap